Jerzy Gumulka

Insider Reports History

Entity
Individual
Location
C/O Cns Pharmaceuticals, Inc., 2100 West Loop South Ste 900, Houston, TX
Signature
/s/ Christopher Downs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jerzy Gumulka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Director Restricted Stock Units 148K $44.3K $0.30 Apr 8, 2024 Direct
CNS Pharmaceuticals, Inc. Director Common stock 43K $12.9K $0.30 Feb 1, 2024 Direct
CNS Pharmaceuticals, Inc. Director Option to purchase common stock 130K Apr 8, 2024 Direct
CNS Pharmaceuticals, Inc. Director Series B Warrant to purchase common stock 112K Feb 1, 2024 Direct
CNS Pharmaceuticals, Inc. Director Series A Warrant to purchase common stock 78.8K Feb 1, 2024 Direct

Insider Reports Filed by Jerzy Gumulka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNSP CNS Pharmaceuticals, Inc. Apr 8, 2024 2 $0 4 Apr 10, 2024 Director
CNSP CNS Pharmaceuticals, Inc. Feb 1, 2024 3 $10K 4 Feb 6, 2024 Director
CNSP CNS Pharmaceuticals, Inc. Sep 21, 2023 1 $0 4/A Oct 12, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Apr 19, 2023 1 $4.25K 4 Apr 21, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Apr 10, 2023 1 $5.31K 4 Apr 17, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director